The Abu Dhabi Market
Abu Dhabi's Pharmaceuticals & Life Sciences market — shaped by ADGM's English common law financial center, ADIO's technology investment mandate, and the concentration of sovereign wealth infrastructure — operates under both federal UAE frameworks and Abu Dhabi-specific regulatory requirements. The ADGM Financial Services Regulatory Authority, DOH healthcare oversight, and ADDED's economic development frameworks create a layered compliance environment.
Engineering teams serving Abu Dhabi Pharmaceuticals & Life Sciences organizations need ADGM FSRA requirements, DOH digital health standards, and federal UAE frameworks (PDPL, NESA) mapped simultaneously. The Abu Dhabi regulatory environment is meaningfully distinct from Dubai — applying Dubai compliance documentation to Abu Dhabi engagements is a common and expensive mistake.
Compliance Coverage
Every system we deploy for Pharmaceuticals & Life Sciences in Abu Dhabi is FDA 21 CFR Part 11-compliant from architecture through deployment. FDA 21 CFR Part 11 and HIPAA compliance is enforced automatically at every commit — not assessed after the fact.
Engagement Scope
Duration: 8–16 weeks
A focused team deployed against a single Pharmaceuticals & Life Sciences platform in Abu Dhabi. FDA 21 CFR Part 11 and HIPAA-compliant architecture from day one. Fixed price, fixed output, no discovery phase.
Duration: 3–9 months
40–100 engineers running parallel workstreams across a Pharmaceuticals & Life Sciences transformation in Abu Dhabi. Multi-system compliance governance and FDA 21 CFR Part 11 and HIPAA certification maintained across the full program.
Duration: 6–18 months
100–250+ engineers owning the complete technology infrastructure for a Pharmaceuticals & Life Sciences organization in Abu Dhabi. Full FDA 21 CFR Part 11 and HIPAA compliance across every system, every integration, every deployment.